{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:05:20Z","timestamp":1791518720267,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11126-016-9421-7","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T21:18:07Z","timestamp":1455743887000},"page":"763-767","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Abuse of Gabapentin is Associated with Opioid Addiction"],"prefix":"10.1007","volume":"87","author":[{"given":"Leo","family":"Bastiaens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Galus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherise","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"key":"9421_CR1","unstructured":"Volkow ND: https:\/\/www.drugabuse.gov\/publications\/research-reports\/prescription-drugs\/director , 2014."},{"key":"9421_CR2","unstructured":"Centers for Disease Control and Prevention: Vital Signs: Overdoses of prescription opioid pain relievers\u2014United States, 1999\u20132008. www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6043a4.htm , 2011."},{"key":"9421_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2009.01.007","volume":"102","author":"SE McCabe","year":"2009","unstructured":"McCabe SE, Boyd CJ, Teter CJ: Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 102:63\u201370, 2009.","journal-title":"Drug and Alcohol Dependence"},{"key":"9421_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3200\/JACH.54.5.269-278","volume":"54","author":"SE McCabe","year":"2006","unstructured":"McCabe SE, Teter CJ, Boyd CJ: Medical use, illicit use, and diversion of abusable prescription drugs. Journal of American College Health 54:269\u2013278, 2006.","journal-title":"Journal of American College Health"},{"key":"9421_CR5","doi-asserted-by":"crossref","unstructured":"Reeves RR, Burke RS: Abuse of combinations of gabapentin and quetiapine. The Primary Care Companion for CNS Disorders 16(5):11, 2014.","DOI":"10.4088\/PCC.14l01660"},{"key":"9421_CR6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3399\/bjgp12X653516","volume":"62","author":"BH Smith","year":"2012","unstructured":"Smith BH, Higgins C, Baldacchino A, et al.: Substance misuse of gabapentin. British Journal of General Practice 62:406\u2013407, 2012.","journal-title":"British Journal of General Practice"},{"key":"9421_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/10550490490460300","volume":"13","author":"L Reccoppa","year":"2004","unstructured":"Reccoppa L, Malcolm R, Ware M: Gabapentin abuse in inmates with prior history of cocaine dependence. American Journal on Addictions 13:321\u2013323, 2004.","journal-title":"Am J Addict."},{"key":"9421_CR8","unstructured":"Del Paggio D: Psychotropic medication abuse in correctional facilities. http:\/\/www.acbhcs.org\/Psychopharmacology\/2005\/June2005.pdf , 2005."},{"key":"9421_CR9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JCP.0b013e318295fe2f","volume":"33","author":"RR Reeves","year":"2013","unstructured":"Reeves RR, Ladner ME: Additional evidence of the abuse potential of bupropion. Journal of clinical psychopharmacology 33:584\u2013585, 2013.","journal-title":"J Clin Pyschopharmacol."},{"key":"9421_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1078345813486448","volume":"19","author":"WT Hilliard","year":"2013","unstructured":"Hilliard WT, Barloon L, Farley P, et al.: Bupropion diversion and misuse in the correctional facility. Journal of Correctional Health Care 19:211\u2013217, 2013.","journal-title":"J Correct Health Care."},{"key":"9421_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2014.12159.x","author":"T Wilens","year":"2014","unstructured":"Wilens T, Zulauf C, Ryland D, et al.: Prescription medication misuse among opioid dependent patients seeking inpatient detoxification. The American Journal on Addictions. doi: 10.1111\/j.1521-0391.2014.12159.x , 2014.","journal-title":"Am. J Addiction."},{"key":"9421_CR12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000355268","volume":"20","author":"CRW Baird","year":"2014","unstructured":"Baird CRW, Fox P, Colvin LA: Gabapentinoid abuse in order to potentiate the effect of methadone: A survey among substance misusers. European Addiction Research 20:115\u2013118, 2014.","journal-title":"European Addiction Research"},{"key":"9421_CR13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0278-5846(01)00234-2","volume":"26","author":"V Bozikas","year":"2002","unstructured":"Bozikas V, Petrikis P, Gamvrula K, et al.: Treatment of alcohol withdrawal with gabapentin. Progress in Neuro-Psychopharmacology and Biological Psychiatry 26:197\u2013199, 2002.","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"9421_CR14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1399-5618.2000.20305.x","volume":"2","author":"AC Pande","year":"2000","unstructured":"Pande AC, Crockatt JG, Janney.A, et al.: Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Bipolar Disorders 2:249\u2013255, 2000.","journal-title":"Bipolar Disorders"},{"key":"9421_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004714-200008000-00011","volume":"20","author":"AC Pande","year":"2000","unstructured":"Pande AC, Pollack MH, Crockatt J, et al.: Placebo-controlled study of gabapentin treatment of panic disorder. Journal of Clinical Psychopharmacology 20:467\u2013471, 2000.","journal-title":"J. Clin Psychopharm."},{"key":"9421_CR16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00004714-199908000-00010","volume":"19","author":"AC Pande","year":"1999","unstructured":"Pande AC, Davidson JRT, Jefferson, JW: Treatment of social phobia with gabapentin: A placebo-controlled study Journal of Clinical Psychopharmacology 19: 341\u2013348, 1999.","journal-title":"J Clin Psychopharm."},{"key":"9421_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.157.1.151","volume":"157","author":"M Karam-Hage","year":"2000","unstructured":"Karam-Hage M, Brower KJ: Gabapentin treatment for insomnia associated with alcohol dependence. American Journal of Psychiatry. 157:151, 2000.","journal-title":"American Journal of Psychiatry"},{"key":"9421_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0920-1211(98)00121-1","volume":"35","author":"L Rocha","year":"1999","unstructured":"Rocha L, Ondarza-Rovira R, Maidment NT: Gabapentin modifies extracellular opioid peptide content in amygdala: A microdialysis study. Epilepsy Research 35:13\u201320, 1999.","journal-title":"Epilepsy Research"},{"key":"9421_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","volume":"35","author":"GF Koob","year":"2010","unstructured":"Koob GF, Volkow ND: Neurocircuitry of addiction. Neuropsychopharmacology 35:217\u2013238, 2010.","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-016-9421-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11126-016-9421-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-016-9421-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-016-9421-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:27:06Z","timestamp":1559359626000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11126-016-9421-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9421"],"URL":"https:\/\/doi.org\/10.1007\/s11126-016-9421-7","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]}}}